Idexx Laboratories (IDXX) Price to Sales (2009 - 2026)

Idexx Laboratories has reported Price to Sales for 18 years, with the latest figure at 34.13 in Q2 2026.

• On a quarterly basis, Price to Sales fell 11.91% year-over-year to 34.13 in Q2 2026; TTM through Jun 2026 was 9.12, a 14.34% decrease from a year earlier, with the FY2025 full-year figure at 12.53, up 44.75% from the prior year.
• Price to Sales was 34.13 for Q2 2026 at Idexx Laboratories, down from 39.03 in the prior quarter.
• The five-year high for Price to Sales was 55.04 in Q1 2022, with the low at 32.13 in Q3 2022.
• Average Price to Sales over 5 years is 41.61, with a median of 40.43 recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Price to Sales plunged 50.68% in 2022, then soared 39.87% in 2025.
• Over 5 years, Price to Sales stood at 40.81 in 2022, then increased by 25.24% to 51.12 in 2023, then slumped by 30.84% to 35.35 in 2024, then soared by 39.87% to 49.45 in 2025, then tumbled by 30.98% to 34.13 in 2026.
• The last three Price to Sales figures came in at 34.13 (Q2 2026), 39.03 (Q1 2026), and 49.45 (Q4 2025), per Business Quant data.